4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-22-021376
Options or other derivatives
- Chief Development Officer acquired 311,437 shares (grant or award)
- Chief Development Officer returned 311,437 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
LeBel Carl · Chief Development Officer
Table II: Derivative
6 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-08-17 | Grant or award : show line 1 in the form Stock Option | +178,937 | $2.14 | 2029-10-01 | 178,937 | 178,937 | D |
| 2022-08-17 | Returned to the company : show line 2 in the form Stock Option | −178,937 | $14.00 | 2029-10-01 | 178,937 | 0 | D |
| 2022-08-17 | Grant or award : show line 3 in the form Stock Option | +75,000 | $2.14 | 2031-01-14 | 75,000 | 75,000 | D |
| 2022-08-17 | Returned to the company : show line 4 in the form Stock Option | −75,000 | $35.85 | 2031-01-14 | 75,000 | 0 | D |
| 2022-08-17 | Grant or award : show line 5 in the form Stock Option | +57,500 | $2.14 | 2030-02-11 | 57,500 | 57,500 | D |
| 2022-08-17 | Returned to the company : show line 6 in the form Stock Option | −57,500 | $25.05 | 2030-02-11 | 57,500 | 0 | D |
Loading xslF345X03/form4.xml…